Showing results (641-650 of 2,688) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|March 21, 2026
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmapElly van Riet, Björn Corleis, Birgitte K Giersing, et al.
The Lancet. Infectious Diseases|May 27, 2026
Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trialBilly J Quilty, Michiko Toizumi, Hien Anh Thi Nguyen, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
The Lancet. Infectious Diseases|July 3, 2023
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational studySho Nakakubo, Naoki Kishida, Kenichi Okuda, et al.
The Lancet. Infectious Diseases|June 23, 2023
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trialJing-Xin Li, Li-Hua Hou, Jin-Bo Gou, et al.
The Lancet. Infectious Diseases|July 8, 2023
The importance of getting the ethics right in a pandemic treatyG Owen Schaefer, Caesar A Atuire, Sharon Kaur, et al.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The Lancet. Infectious Diseases|June 22, 2023
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infectionNoé Brasier, H Ceren Ates, Juliane R Sempionatto, et al.
The Lancet. Infectious Diseases|March 26, 2026
Methodological quality assessment tool for observational studies comparing treatment effectiveness in infectious diseases: a Delphi consensus and application to studies on bloodstream infections due to carbapenem-resistant EnterobacteralesGiulia Zumbo, Martina Beltrami, Jose M Bravo-Ferrer, et al.
The Lancet. Infectious Diseases|March 28, 2026
Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort studyMorgan K Walker, Christina Yek, Sadia Sarzynski, et al.
Pageof 269